Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Iciar García"'
Autor:
Marcos Cruz-Montijano, Mariano Amo-Salas, Javier Cassinello-Espinosa, Iciar García-Carbonero, Jose Carlos Villa-Guzman, Ana Maria Garcia-Vicente
Publikováno v:
Cancers, Vol 16, Iss 15, p 2695 (2024)
Purpose: We aimed to develop a nomogram able to predict treatment failure, skeletal events, and overall survival (OS) in patients with castration-resistant prostate cancer with bone metastases (CRPC-BM) treated with Radium-223 dichloride (223Ra). Pat
Externí odkaz:
https://doaj.org/article/5f8907ecc78d46cbbd5046de2b9cbba5
Autor:
Iciar García Martínez
Publikováno v:
Miscelánea Comillas, Vol 70, Iss 136, Pp 39-89 (2013)
Objective, determining the main reasons for social isolation on women and analysing the intervention lines. Methods, a qualitative study focused on secondary sources analysis and surveys. Results and Conclusions, the homeless nessprofile has changed.
Externí odkaz:
https://doaj.org/article/1b6c2d8934bf458cb47ad5a4fae9a449
Autor:
Rodríguez-Sanz, Álvaro, Cordero García, José Manuel, Ovies-Carro, Icíar García, Iglesias, Enrique
Publikováno v:
In Transportation Research Procedia 2021 58:5-12
Autor:
Guillermo de Velasco, Teresa Alonso-Gordoa, Alejo Rodríguez-Vida, Georgia Anguera, Marc Campayo, Álvaro Pinto, Esther Martínez Ortega, Enrique Gallardo, Natalia Fernández Núñez, Iciar García-Carbonero, Oscar Reig, María José Méndez-Vidal, Ovidio Fernández-Calvo, Natalia Vidal Cassinello, Dolores Torregrosa, Ana López-Martín, Adriana Rosero, Patricia G. Valiente, Carmen Garcías de España, Miguel A. Climent, Montserrat Domenech Santasusana, Ángel Rodríguez Sánchez, Isabel Chirivella González, Ruth Afonso, Xavier García del Muro, Javier Casinello, Eva M. Fernández-Parra, Lourdes García Sánchez, Javier Afonso, Susana Hernando Polo, Úrsula Asensio
Publikováno v:
Clinical Genitourinary Cancer. 21:e166-e174
The long-term clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) and a complete response (CR) to the tyrosine kinase inhibitor (TKI) sunitinib are poorly known. The characteristics of these patients could reveal previously unde
Autor:
Angelergues, Antoine, Efstathiou, Eleni, Gyftaki, Revekka, Wysocki, Piotr Jan, Lainez, Nuria, Gonzalez, Iria, Castellano, Daniel E., Ozguroglu, Mustafa, Carbonero, Iciar Garcia, Flechon, Aude, Borrega, Pablo, Guillot, Aline, Balea, Begona Campos, Le Moulec, Sylvestre, Esteban, Emilio, Munarriz, Javier, Rubio, Gustavo, Birtle, Alison J., Delanoy, Nicolas, Bellmunt, Joaquim, Oudard, Stéphane
Publikováno v:
In Clinical Genitourinary Cancer August 2018 16(4):e777-e784
Autor:
Laura Villalobos-León, Iciar García, María Garrido Arévalo, Urbano Anido, Julia Llinares, O. Fernández, Arancha García, Alvaro Pinto, Xavier Garcia del Muro, J. Lambea, José Carlos Villa-Guzmán, Francisco Zambrana, Enrique Gallardo, M. Victoria Bolós, Alejandro Velastegui, Jesús García-Donas, José Muñoz-Langa, Antonio Viana, Esther Martínez-Ortega, María José Méndez-Vidal, Clara Iglesias, Susana Hernando-Polo, Daniel Castellano, Sara Cerezo, Carmen Santander, Martín Lázaro-Quintela, Miguel Angel Climent, Georgia Anguera, Laia Capdevila, Isabel Chirivella, Carolina Hernández, Alejo Rodriguez-Vida, Cristina Suárez, Sergio Vázquez, Aranzazu Gonzalez del Alba, Marc Campayo, Teresa Alonso, Miguel Sotelo, Ángel Rodríguez-Sánchez, Nuria Lainez, Gustavo Rubio, Òscar Reig, Rosa García-Marrero
Publikováno v:
CLINICAL GENITOURINARY CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical Genitourinary Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Banco de España
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical Genitourinary Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Banco de España
Background : Axitinib monotherapy obtained approval in pre-treated metastatic renal cell carcinoma (mRCC) patients and recently in combination with pembrolizumab or avelumab in the first-line setting. However, patient profiles that may obtain increas
Autor:
Guillermo de Velasco, Iciar García-Carbonero, Emilio Esteban-Gonzalez, Alvaro Pinto, David Lorente, Alfonso Gomez De Liano Lista, Esther Martínez Ortega, Laura Jimenez Colomo, Javier Puente, Iria Gonzalez, Ovidio Fernandez-Calvo, Georgia Anguera
Publikováno v:
Journal of Clinical Oncology. 41:502-502
502 Background: Urothelial carcinoma (UC) commonly affects patients (pts) who are ineligible for full doses of cisplatin-based chemotherapy (CT) due to bad performance status, advanced age, or renal impairment. The combination of split-dose cisplatin
Autor:
Xavier García-del-Muro, Ignacio Durán, Jose Luis Perez-Gracia, Miguel Ángel Climent, Begoña Mellado, Juan A. Virizuela, Daniel E. Castellano, Aranzazu González del Alba, Iciar García Carbonero, Carlos Álvarez-Fernández, Jesús García-Donas, Marta Gil-Martin, Alvaro-González Hernández
Publikováno v:
Clinical Genitourinary Cancer. 20:388.e1-388.e10
The therapeutic repertoire available for advanced renal cell carcinoma (RCC), including tyrosine kinase inhibitors (TKIs) and immunotherapy, required for molecular biomarkers for response.This was a phase I to II trial on the combination of pazopanib
Autor:
Javier Casinello, Pablo Gajate, Laura Rodriguez, Almudena Martin, Ma Laura Villalobos, Lourdes García, Javier Espinosa, Teresa Alonso Gordoa, Juan Francisco Rodriguez, Jesús García-Donas, Isabel Gallegos, Iciar García, Carlos Aguado, Alvaro Pinto, Ana Herrero, J. A. Arranz, Maria del Prado Garrido, Edinson Caviedes, Constanza Maximiano, Enrique Grande, Javier Puente
Publikováno v:
Kidney Cancer. 3:41-50
Non-clear cell renal cell carcinoma (nccRCC) represents a group of multiple histologic subtypes, with different clinical outcomes and an uncertain optimal treatment. Data collected in clear cell tumors are routinely extrapolated to nccRCC, despite a
Autor:
Francisco Lendinez-Molinos, Jose Eugenio Cabrera-Sevilla, Antonio Bonillo-Perales, Iciar García-Escobar, María A Vázquez-López, Sara Gómez-Bueno, María Ortiz Pérez
Publikováno v:
European journal of pediatrics. 180(6)
The objective of this study is to establish reference values for folic acid in a healthy population of children aged 4-11 years and to examine related epidemiological, dietary and analytical factors. A cross-sectional study of 658 healthy children ag